JW Therapeutics Initiates Phase I Study of JWATM204 for Hepatocellular Carcinoma
China-based JW Therapeutics (HKG: 2126) announced the initiation of a Phase I clinical study for...
Cell-therapy
Fosun Pharmaceutical and ReNeuron Renew CTX Cell Therapy Deal for China
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has negotiated a new...
Harbour BioMed’s Partner NK Celltech Raises RMB 100M in Series A Financing
China-based Harbour BioMed (HKG: 2142) announced that its strategic partner NK Celltech, a company focusing...
Legend Biotech Collaborates with Trinity College Dublin on CAR-T Therapies for Solid Tumors
China-based Legend Biotech Corporation (NASDAQ: LEGN) has formed a partnership with Trinity College Dublin and...
Eureka Biotechnology Secures RMB 100 Million for Cell and Gene Therapy Solutions
Shenzhen-based Eureka Biotechnology, a company specializing in comprehensive solutions for the cell and gene therapy...
Cellular Biomedicine Group’s C-CAR039 Receives NMPA Approval for B-Cell NHL Study
China-based Cellular Biomedicine Group Inc. (CBMG), a private company following a merger deal in February...
Global Cord Blood Corp’s Cellenkos Gets FDA Nod for Myelofibrosis Trial
Global Cord Blood Corporation (GCBC; NYSE: CO) announced receiving Investigational New Drug (IND) approval from...
WuXi ATU Partners with Wugen to Accelerate NK Cell Therapy Development
WuXi ATU, the gene and cell therapy-focused CTDMO unit of WuXi Apptec (SHA: 603259, HKG:...
Ascentage Pharma’s Lisaftoclax Shows Promising Results in Phase I Trial for Non-Hodgkin Lymphoma
Suzhou-based Ascentage Pharma (HKG: 6855) announced the publication of Phase I clinical study results for...